Yifan

• Audited biotech pitches with the Executive Director team; evaluated asset quality and early-stage commercial viability.
• Led market research and drafted investment theses on radionuclide drug conjugates (RDC) and natural orifice surgical robots.
• Represented INCE at CBIIC 2025 and connected with startup executives for pipeline sourcing.

• Supported pipeline forecasting and go/no-go evaluation by integrating MoA, TPP, clinical evidence, and competition mapping.
• Coordinated cross-functional collaboration across R&D, Clinical, CMC, and Regulatory Affairs to align lifecycle strategy.
• Supported licensing-in/out and New-Co due diligence; handled technical documentation transfer for overseas clinical development.
• Applied Six Sigma and SIPOC methods to improve internal project workflows.

Dissected the role of basal forebrain cholinergic neurons in cingulate cortex regulation and visual attention.

Developed time-series models linking behavioral events with acetylcholine dynamics.

Selected output:

• Co-author, Nature Communications (2023): frontal transcallosal inhibition loop mediating interhemispheric balance in visuospatial processing.

Led bioinformatics research on hepatoblastoma and optimized multi-omics analysis to characterize tumor microenvironment heterogeneity.

Selected output:

• Co-first author, STAR Protocols (Cell Press, 2023): protocol for wide-diversity single-cell dissociation and isolation from hepatoblastoma tissue.